With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Natural Killer T cells with an IL-15-armored GD2-specific CAR for Children with Neuroblastoma||Baylor College of Medicine / Andras Heczey, MD||Bio-Therapeutic Impact Award||2017||Texas|
|Next-Generation Personalized Neuroblastoma Therapy (Nepenthe)||Children's Hospital of Philadelphia / Yael Mosse, MD & John Maris, MD||Bio-Therapeutic Impact Award||2015||Pennsylvania|
|Molecular Annotation for Treatment of Childhood Cancers Trial: Neuroblastoma (MATCH-NB)||Children's Hospital of Philadelphia / Yael Mosse,M.D.||Bio-Therapeutic Impact Award||2015||Pennsylvania|
|HA-1 TCR T-cell Immunotherapy for Acute Leukemia||Fred Hutchinson Cancer Research Center / Marie Bleakley, M.D., Ph.D.||Bio-Therapeutic Impact Award||2014||Washington|
|Phase I Trial of Indoximod in Combination with Temozolomide-based Therapy for Children with Progressive Primary Brain Tumors||Georgia Health Sciences University Research Institute, Inc. / Theodore Johnson, M.D., Ph.D.||Bio-Therapeutic Impact Award||2014||Georgia|
|Immunotherapy of Neuroblastoma with CAR.GD2 NKT Cells||Baylor College of Medicine / Leonid S. Metelitsa, M.D., Ph.D.||Bio-Therapeutic Impact Award||2014||Texas|
|Astatine-211 Meta-Astatobenzylguanidine ([211At]MABG) Targeted Radiotherapy for Disseminated Neuroblastoma||Children's Hospital of Philadelphia / John Maris, MD||Reach Grants||2016||Pennsylvania|
|Novel Genomic Diagnostics for Intracranial Germ Cell Tumors||Connecticut Children's Medical Center Foundation, Inc. / Ching Lau, MD/PhD||Reach Grants||2021||Connecticut|
|Adoptive Immunotherapy of Tr1 Cells to Improve Outcome of Allo-HSCT Treatment for Pediatric AML||Stanford University / Maria-Grazia Roncarolo, MD & Rosa Bachetta, MD||Reach Grants||2015||California|
|Generation of CMV-specific CD19 CAR T cells Using Cytokine Capture Followed by Lentiviral Transduction and Expansion||Research Institute at Nationwide Children's Hospital / Margaret Lamb, MD||Reach Grants||2019||Ohio|